Clophide 500 Injection contains Cyclophosphamide 500mg, a potent alkylating agent widely used in oncology for treating various solid tumors and hematological cancers. It is trusted in chemotherapy protocols for breast cancer, Hodgkin’s and non-Hodgkin’s lymphomas, multiple myeloma, leukemia, and ovarian cancers, making it one of the most essential medicines in cancer therapy.
Cyclophosphamide works by disrupting DNA replication in rapidly dividing cancer cells, helping slow tumor growth and enhance treatment outcomes. This 500mg strength is commonly used in infusion regimens across hospital oncology departments, ensuring precision dosing and strong therapeutic activity in combination therapy protocols.
For oncology distributors, Clophide 500 Injection serves as a high-demand essential cancer-care product, frequently required in IPD units, multispecialty hospitals, government cancer institutes, private oncology centers, and day-care chemotherapy facilities. Its continuous prescription demand ensures consistent market movement.
Adding Clophide 500 to your product range strengthens your oncology and chemotherapy segment, creating opportunities for hospital supplies, institutional tenders, oncology pharmacy distribution, export consignments, and third-party manufacturing partnerships. Its clinical importance and wide usage make it a valuable and profit-driving addition for pharmaceutical distributors.